Valiant Organics

Which are the latest news on Valiant Organics?

Why is Valiant Organics Ltd falling/rising?

As of 05-Sep, Valiant Organics Ltd's stock price is at Rs 323.75, reflecting a 1.25% increase. The stock has gained 9.23% over the past week and 11.64% over the last month, outperforming the Sensex, with increased investor interest indicated by a significant rise in trading volume.

As of 05-Sep, Valiant Organics Ltd's stock price is rising, currently at Rs 323.75, which reflects an increase of Rs 4.0 or 1.25%. This upward movement is supported by several factors. Over the past week, the stock has shown a significant gain of 9.23%, contrasting sharply with the Sensex, which has declined by 0.97%. Additionally, in the last month, Valiant Organics has risen by 11.64%, while the Sensex has fallen by 2.44%. Year-to-date, the stock has increased by 18.05%, while the benchmark has decreased by 10.21%.<BR><BR>Today's performance indicates that the stock is in line with its sector, and it has recently experienced a trend reversal after three consecutive days of gains. The stock reached an intraday high of Rs 330.95, marking a 3.5% increase. Furthermore, Valiant Organics is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive indicator of its price momentum.<BR><BR>Investor participation has also increased, with a delivery volume of 7.87k on September 3, which is up by 236.63% compared to the 5-day average. This rise in trading volume suggests growing interest among investors. The liquidity of the stock is adequate, allowing for trades of Rs 0.03 crore based on 2% of the 5-day average traded value. Overall, these factors contribute to the stock's rising price.

Who are in the management team of Valiant Organics?

The management team of Valiant Organics includes Chairman Navin Chapshi Shah, Managing Director Arvind Chheda, and several other executive and non-executive directors, responsible for the company's strategic direction and operations.

The management team of Valiant Organics includes the following individuals:<BR><BR>1. **Navin Chapshi Shah** - Chairman & Independent Director<BR>2. **Arvind Chheda** - Executive Director, Managing Director, Chief Financial Officer, and Promoter<BR>3. **Mahek Manoj Chheda** - Executive Director & Wholetime Director<BR>4. **Nemin Mahesh Savadia** - Executive Director<BR>5. **Sathiababu Krishnan Kallada** - Non-Executive & Non-Independent Director<BR>6. **Siddharth D. Shah** - Executive Director<BR>7. **Vishnu Sawant** - Executive Director & Wholetime Director<BR>8. **Kiritkumar Haribhai Desai** - Non-Executive & Non-Independent Director<BR>9. **Santosh S. Vora** - Non-Executive Director<BR>10. **Mulesh Manilal Savla** - Independent Non-Executive Director<BR>11. **Sonal A Vira** - Independent Director<BR>12. **Sudhirprakash Baburao Sawant** - Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and operations.

What does Valiant Organics do?

Valiant Organics Ltd is a specialty chemical manufacturer in the Agro Intermediate and Pharma sectors, with a market cap of INR 845 Cr. As of June 2026, it reported net sales of 232 Cr and a net profit of 29 Cr.

Overview:<BR>Valiant Organics Ltd is a specialty chemical manufacturer operating in the Agro Intermediate and Pharma sectors, categorized as a Micro Cap company.<BR><BR>History:<BR>Valiant Organics Limited was incorporated in 2005 as 'Valiant Organics Private Limited' and later became a Public Limited Company in 2015. The most recent quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 232 Cr (Quarterly Results - Jun 2026)<BR>- Net Profit: 29 Cr (Quarterly Results - Jun 2026)<BR>- Market Cap: INR 845 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 16.00<BR>- Industry P/E: 37<BR>- Dividend Yield: 0.00%<BR>- Debt-Equity: 0.33<BR>- Return on Equity: 3.91%<BR>- Price to Book: 1.09<BR><BR>Contact Details:<BR>Address: 109 Udyog Kshetra 1st Floor, Mulund Goregaon Link Rd Mulund Mumbai Maharashtra : 400080<BR>Tel: 91-22-25913767/3766/67976640/5<BR>Email: investor@valiantorganics.com<BR>Website: http://www.valiantorganics.com

Who are the peers of the Valiant Organics?

Valiant Organics' peers include Sunshield Chem., Sudarshan Pharma, Amal, Indo Amines, Gem Aromatics, Fairchem Organic, Chembond Chemic., DMCC Speciality, and Chemcon Special. In terms of management risk, Valiant Organics has Below Average risk and a 1-year return of -14.14%, better than Gem Aromatics but worse than Chembond Chemic.

Peers: The peers of Valiant Organics are Sunshield Chem., Sudarshan Pharma, Amal, Indo Amines, Gem Aromatics, Fairchem Organic, Chembond Chemic., DMCC Speciality, and Chemcon Special.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sudarshan Pharma and Chembond Chemic., while Average management risk is found at Sunshield Chem., Amal, Fairchem Organic, and DMCC Speciality, and the rest. Below Average management risk is noted for Valiant Organics, Indo Amines, Gem Aromatics, Chemcon Special., and Kronox Lab. In terms of Growth, Excellent growth is seen at Sudarshan Pharma, Good growth at Amal, and the rest have Below Average growth, including Valiant Organics. Capital Structure ratings show Excellent at Chembond Chemic. and Chemcon Special., Good at Fairchem Organic, Average at Valiant Organics, Sunshield Chem., Amal, and DMCC Speciality, and Below Average at Indo Amines, Gem Aromatics.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Chembond Chemic. at 40.64%, while the lowest is Gem Aromatics at -39.13%. Valiant Organics has a 1-year return of -14.14%, which is better than Gem Aromatics but worse than Chembond Chemic. Additionally, peers with negative six-month returns include Gem Aromatics and Indo Amines.

How big is Valiant Organics?

As of 31st August, Valiant Organics Ltd has a market capitalization of 845.00 Cr, with recent net sales of 765.90 Cr and a net profit of 54.09 Cr.

As of 31st August, Valiant Organics Ltd has a market capitalization of 845.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Valiant Organics reported Net Sales of 765.90 Cr and a Net Profit of 54.09 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 725.26 Cr and Total Assets of 1,182.93 Cr.

Should I buy, sell or hold Valiant Organics Ltd?

Are Valiant Organics Ltd latest results good or bad?

Valiant Organics Ltd's latest quarterly results are strong, with a 330.68% increase in net profit and a 36.74% rise in revenue. However, the company has faced two consecutive annual losses and low return on equity, indicating ongoing financial challenges despite the recent positive performance.

Valiant Organics Ltd's latest results present a mixed picture. On the positive side, the company reported a significant turnaround in Q4 FY26, with a consolidated net profit of ₹15.72 crores, reflecting a remarkable 330.68% increase quarter-on-quarter. Revenue also saw a substantial rise of 36.74% to ₹217.78 crores, marking the highest quarterly revenue in the company's recent history. The operating margin improved to 12.16%, indicating a recovery from previous quarters.<BR><BR>However, despite this strong quarterly performance, the overall annual results raise concerns. For FY25, Valiant Organics reported a marginal net loss of ₹2 crores on revenues of ₹718 crores, representing a slight decline in sales compared to the previous year. This marked the second consecutive year of losses, following a ₹6 crore loss in FY24. The company's return on equity (ROE) is also notably low at 3.18%, indicating inefficiencies in generating returns for shareholders.<BR><BR>Additionally, the stock has underperformed compared to the specialty chemicals sector and the broader market, with a 12.53% decline over the past year. This underperformance, combined with concerns about margin volatility and the absence of institutional investor interest, suggests that while the latest quarterly results are strong, they do not fully address the underlying challenges facing the company.<BR><BR>In summary, while the recent quarterly results show promise, the broader context indicates ongoing financial difficulties and operational inefficiencies, making the overall assessment of Valiant Organics' performance more cautious.

When is the next results date for Valiant Organics Ltd?

The next results date for Valiant Organics Ltd is 16 May 2026.

The next results date for Valiant Organics Ltd is scheduled for 16 May 2026.

Is Valiant Organics technically bullish or bearish?

As of December 1, 2025, the trend is mildly bearish due to bearish momentum from the weekly MACD and Bollinger Bands, although monthly indicators suggest potential for recovery.

As of 1 December 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven primarily by the weekly MACD and Bollinger Bands indicating bearish momentum. The daily moving averages also reflect a bearish outlook. However, the monthly MACD and KST show mildly bullish signals, suggesting some potential for recovery over a longer time frame. Overall, the lack of strong bullish signals and the prevailing bearish indicators indicate a cautious approach is warranted.

Is Valiant Organics overvalued or undervalued?

As of November 27, 2025, Valiant Organics is considered overvalued with a PE ratio of 30.94 and an EV to EBITDA of 11.73, especially when compared to peers like Cipla and Sun Pharma, and has underperformed the Sensex with a year-to-date return of -14.77%.

As of 27 November 2025, Valiant Organics has moved from a very attractive to an attractive valuation grade. The company appears to be overvalued based on its current metrics. The PE ratio stands at 30.94, while the EV to EBITDA is 11.73 and the PEG ratio is notably low at 0.18, indicating potential overvaluation compared to growth expectations.<BR><BR>In comparison to its peers, Valiant Organics' valuation seems less favorable. For instance, Sun Pharma has a PE ratio of 37.62 and an EV to EBITDA of 24.87, categorizing it as expensive, while Cipla, also rated attractive, has a PE of 22.67 and an EV to EBITDA of 16.04. Furthermore, Valiant's recent stock performance has lagged significantly behind the Sensex, with a year-to-date return of -14.77% compared to the Sensex's 9.70%, reinforcing the notion that it may be overvalued in the current market context.

How has been the historical performance of Valiant Organics?

Valiant Organics has faced significant fluctuations in financial performance, with net sales declining from 1,051.80 Cr in March 2023 to 718.76 Cr in March 2025, while profitability metrics have also decreased, resulting in a negative profit after tax of -2.67 Cr in March 2025. Despite a slight recovery in operating profit, the overall financial environment remains challenging.

Answer:<BR>The historical performance of Valiant Organics has shown significant fluctuations over the years, particularly in net sales and profitability.<BR><BR>Breakdown:<BR>Valiant Organics reported net sales of 718.76 Cr in March 2025, a slight decline from 723.06 Cr in March 2024 and a notable decrease from 1,051.80 Cr in March 2023. The total operating income mirrored this trend, falling to 718.76 Cr in March 2025 from 723.06 Cr in the previous year and down from 1,051.80 Cr in March 2023. The raw material costs also decreased to 440.07 Cr in March 2025 from 483.40 Cr in March 2024, contributing to a total expenditure of 665.09 Cr in March 2025, which was lower than 684.81 Cr in March 2024. Operating profit (PBDIT) rose to 62.31 Cr in March 2025 from 47.55 Cr in March 2024, but this was significantly lower than the 172.26 Cr reported in March 2023. The profit before tax showed a recovery to 2.91 Cr in March 2025 from a loss of 7.13 Cr in March 2024, yet it was down from 137.18 Cr in March 2023. The profit after tax remained negative at -2.67 Cr in March 2025, although it improved from -6.84 Cr in March 2024. The consolidated net profit also reflected this trend, standing at -3.74 Cr in March 2025 compared to -8.39 Cr in March 2024 and a profit of 88.12 Cr in March 2023. Total assets decreased to 1,182.93 Cr in March 2025 from 1,247.96 Cr in March 2024, while total liabilities also fell to 1,182.93 Cr from 1,247.96 Cr. Cash flow from operating activities was 56.00 Cr in March 2025, down from 84.00 Cr in March 2024, indicating a decline in cash generation capabilities. Overall, Valiant Organics has experienced a challenging financial environment with fluctuating sales and profitability metrics over the past few years.

Who are the top shareholders of the Valiant Organics?

The top shareholders of Valiant Organics include promoter Jaya Chandrakant Gogri with 8.25% and public shareholder Nikhil Parimal Desai with 9.17%. Individual investors hold 37.41%, while 17 foreign institutional investors hold a combined 0.37%, with no pledged promoter holdings or mutual fund investments.

The top shareholders of Valiant Organics include Jaya Chandrakant Gogri, who is the promoter with the highest holding at 8.25%. Additionally, the highest public shareholder is Nikhil Parimal Desai, holding 9.17%. Individual investors collectively hold a significant portion of the company at 37.41%. There are also 17 foreign institutional investors (FIIs) that hold a combined 0.37% of the shares. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

What is the bonus history of the Valiant Organics?

Valiant Organics issued a 1:1 bonus share on December 24, 2020, with a record date of December 28, 2020, effectively doubling shareholders' holdings.

Valiant Organics has a bonus history that includes a notable 1:1 bonus issue announced with an ex-date of December 24, 2020. The record date for this bonus was December 28, 2020. This means that for every share held, shareholders received an additional share, effectively doubling their holdings at that time. If you have any more questions about Valiant Organics or need further details, feel free to ask!

Has Valiant Organics declared dividend?

Valiant Organics Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of February 10, 2023. However, the company has shown significant variability in total returns, with negative returns in longer periods and a dividend yield of 0%.

Valiant Organics Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1 per share<BR>- Ex-date: 10 Feb 23<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 27.24%, the dividend return was 0%, resulting in a total return of 27.24%.<BR><BR>Over the past year, the price return was 10.57%, with a dividend return of 0%, leading to a total return of 10.57%.<BR><BR>In the 2-year period, the price return was -29.27%, the dividend return was 0%, resulting in a total return of -29.27%.<BR><BR>For the 3-year period, the price return was -34.02%, with a dividend return of 0.86%, culminating in a total return of -33.16%.<BR><BR>In the 4-year period, the price return was -72.23%, the dividend return was 0.30%, resulting in a total return of -71.93%.<BR><BR>Over the last 5 years, the price return was -35.84%, with a dividend return of 1.14%, leading to a total return of -34.7%.<BR><BR>Overall, while Valiant Organics has declared a dividend, the total returns over various periods show significant variability, with some periods reflecting negative returns, particularly in the longer term. The absence of a consistent dividend yield further indicates challenges in maintaining shareholder value.